PRF Technologies Ltd. (PRFX) Financials

PRFX Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2023 9.9 million 2.7 million
Sept. 30, 2023 10.9 million 2.2 million
June 30, 2023 8.3 million 1.3 million
March 31, 2023 10.4 million 1.5 million

PRFX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2023 -1.5 million 181000
Sept. 30, 2023 -1.2 million 182000
June 30, 2023 -2.0 million 261000
March 31, 2023 -2.0 million 180000

PRFX Net Income

No data available :(

PRFX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2023 8.0 million - 86000
Sept. 30, 2023 8.6 million - 94000
June 30, 2023 6.2 million - -
March 31, 2023 8.1 million - -

PRFX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2023 1.4 million
Sept. 30, 2023 1.2 million
June 30, 2023 1.1 million
March 31, 2023 1.1 million

PRFX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2023 936 2.7 million 818000 6000
Sept. 30, 2023 8000 589000 763000 -
June 30, 2023 - 1.2 million 1.0 million -
March 31, 2023 - 1.5 million 962000 -

PRFX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2023 - 6000
Sept. 30, 2023 - 3000
June 30, 2023 - 4000
March 31, 2023 - 2000

PRFX

Price: $1.56

52 week price:
1.28
17.95

Earnings Per Share: 149.50 USD

P/E Ratio: 0.02

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Israel

Volume: 9700

Market Capitalization: 125630

Links: